Global Diabetic Neuropathy Market 2014-2018

Price :
Published : May-2014
No. of Pages : 55

Report Description

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors

16. Key Vendor Analysis
16.1 Pfizer Inc.
16.1.1 Business Overview
16.1.2 Key Information
16.1.3 SWOT Analysis
16.2 Eli Lilly and Company
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Janssen Pharmaceuticals Inc.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis

17. Pipeline Analysis
17.1 Phase III Analysis
17.2 Phase II Analysis
17.3 Phase I Analysis
17.4 Discontinued Projects
17.5 Projects on Hold
17.6 Promising Pipeline Molecules
17.6.1 Phase III Promising Pipeline Molecules
17.6.2 Phase II Promising Pipeline Molecules
17.7 Other First-in-class Pipeline Molecules:

18. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Diabetic Neuropathy Market 2013-2018 (US$ billion)
Exhibit 3: Global Diabetic Neuropathy Market by Geographical Segmentation 2013
Exhibit 4: Eli Lilly and Company: Business Segmentation
Exhibit 5: Diabetic Neuropathy Pipeline Snapshot 2013
Exhibit 6: Discontinued Pipeline Molecules on the basis of MOA

Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Healthcare IT Market in India 2015-2019

Healthcare IT refers to the use of IT services, products, software, and solutions by healthcare organizations to integrate and streamline various processes. In healthcare, IT is used to develop a secure environment and maintain a uniform flow of information. It improves the quality and efficiency of the services delivered and helps in reducing errors in the Healthcare industry. The rising number of healthcare institutions and the emerging need to modernize the same is contributing to the growth of healthcare IT. TechNavio's analysts forecast the Healthcare IT market in India to grow at a CAGR of 14.02 percent over the period 2014-2019. Covered in this Report This report covers the present scenario and the growth prospects of the Healthcare IT market in India for the period 2015-20......
$2500

Healthcare IT Market in Africa 2015-2019

Healthcare IT refers to the use of IT services, products, software, and solutions by healthcare organizations to integrate and streamline various processes. In healthcare, IT is primarily used to develop a secure environment and maintain a uniform flow of information. It improves the quality and efficiency of the services delivered and helps in reducing errors in the Healthcare industry. The rising number of healthcare institutions and the emerging need to modernize the same is proliferating the growth of healthcare IT. TechNavio's analysts forecasts the Healthcare IT market in Africa to grow at a CAGR of 10.04 percent over the period 2014-2019. Covered in this Report The Healthcare IT market is Africa is categorized into three segments: Hardware, Software, and Services. TechNa......
$2500

Global Infertility Market 2015-2019

Infertility is a widespread problem, and it is the inability to conceive after having regular unprotected sex. In one-third of the cases, infertility is because of either female infertility factors or male infertility factors. In rest of the cases, the cause is either unknown or a combination of both male and female factors. In males, infertility is due to a couple of factors including low sperm production, abnormal sperm function, or blockages that prevent the delivery of sperm. The cause of infertility can be difficult to diagnose, but many treatments are available. Treatment options depend on underlying problems. TechNavio's analysts forecast the Global Infertility market to grow at a CAGR of 4.52 percent over the period 2014-2019. Covered in this Report This report covers the ......
$2500

Global Transplantation Market 2015-2019

Transplantation is the procedure in which diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore the normal functions of the body. Organs such as kidneys, liver, heart, lungs, intestine, pancreas, and thymus can be transplanted. Some tissues such as cornea, bones, tendons, heart valves, skin, nerves, and veins can also be replaced with specific alternative tissues. Kidney transplantation is the most common transplantation procedure worldwide, followed by liver and heart transplantations. Cornea and musculoskeletal grafts transplantations are the most common tissue transplantation procedures. The following are the products required during a transplantation procedure: transplantation tissue products, immunosuppressant drugs, and organ pre......
$3000

Global Preventable Vaccines Market 2015-2019

Vaccines can be defined as a product that stimulates a person's immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose. Vaccines can be used for both adults and infants and adolescents. Pediatric vaccines are used for the immunization of children to give protection against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, and adolescent, ranging from birth to 21 years of age. However, the EMA classifies pediatrics as ranging from b......
$3000

Cystic Fibrosis Market in Europe 2015-2019

Cystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic fibrosis is one of the most common genetic disorders observed in Caucasian children. Rare diseases are those that affect less than 5 patients per 10,000, as defined in the EU by Rare Disease UK. Cystic fibrosis is therefore classified under rare diseases. The incidence of cystic fibrosis varies between populations. It is significantly less common in Asian and African populations compared to Caucasians (people from Europe, North America, and Australasia), with a marked difference......
$3000

Global Scar Treatment Market 2015-2019

Scars are treated using both invasive techniques such as surgery and non-invasive techniques such as OTC treatment products. These products and procedures are used to treat all types of scars, such as keloid scars, contracture scars, hypertrophic scars, and atrophic scars. Scars caused by surgery can be removed by surgical revisions, although most people are reluctant to go for another invasive procedure after a surgery. Apart from the easily available OTC scar treatment products, patients can also opt for less-known alternatives such as cryotherapy, clinical peel, and compression. TechNavio's analysts forecast the Global Scar Treatment market to grow at a CAGR of 9.09 percent over the period 2014-2019. Covered in this Report The Global Scar Treatment market can be divided into th......
$2500

Generic Drugs Market in Japan 2015-2019

A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs. Generic drugs help the manufacturer by eliminating the need to develop and market a new drug. As the patent approaches expiration, manufacturers can apply to the FDA for approval to manufacture and sell generic versions of the drug. Generic drugs are equal to and within the bioequivalence range of branded drugs. Tec......
$2500

LBS Market in the US in the Healthcare Industry 2015-2019

LBS are used to track the location of users within a wireless network with the help of location-enabled mobile devices. LBS use GIS technology and the internet to track the location of users. User-initiated LBS require an internet connection to obtain the user's location and provide search results. LBS work on Wi-Fi and RTLS technology to track indoor locations, and are used in hospitals for indoor navigation, location-based messaging, asset management, staff tracking and location analytics. Hospitals are using LBS to enhance employee productivity and work efficiency. TechNavio's analysts forecast the LBS Market in Healthcare Industry in US to grow at a CAGR of 33.61percent over the period 2015-2019. Covered in this Report The LBS Market in Healthcare Industry in US can be segment......
$2500

Global Pharmacy Automation Market 2015-2019

Pharmacy automation system is an effective tool to minimize prescription errors and ensure patient safety. It is a system to automate workflow process and eliminate medication errors during packaging and dispensing in the field of medicine and healthcare. Pharmacy automation involves medicine counting, mixing and measuring liquids and powders for compounding, updating customer database, and inventory management. While maintaining accuracy level, the system can bring new business without hiring and training new staff. TechNavio's analysts forecast the Global Pharmacy Automation market to grow at a CAGR of 7.01 percent over the period 2014-2019. Covered in this Report The Global Pharmacy Automation market can be segmented into: Automated Medication Dispensing, Automated Storage and ......
$2500